Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Open-label Phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients
Keyur Patel
, Seng G. Lim
, Chow W. Cheng
,
Eric Lawitz
, Hans L. Tillmann
, Narinder Chopra
, Ralf Altmeyer
, John C.R. Randle
, John G. McHutchison
Division of Gastroenterology
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Open-label Phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis C
100%
Sertraline
80%
Simvastatin
80%
RNA
60%
Antivirus Agent
60%
Deterioration
40%
Statin (Protein)
40%
Drug Combination
20%
Oxidoreductase
20%
Adverse Event
20%
Membrane Protein
20%
Inflammation
20%
Selective Serotonin Reuptake Inhibitor
20%
Antiviral Activity
20%
Coenzyme A
20%
Anti-Inflammatory Drug
20%
Biochemistry, Genetics and Molecular Biology
Sertraline
80%
Simvastatin
80%
RNA
60%
Genotyping
20%
Reductase
20%
Membrane Protein
20%
Coenzyme A
20%
Selective Serotonin Reuptake Inhibitor
20%
Antiviral Activity
20%
Age
20%
In Vivo Study
20%
Protein Prenylation
20%